Repurposing the Pap smear: one step closer to gynecologic cancer screening.
Where this comes from
- Record sourced from PubMed, PMID 23303602.
- Also identified by DOI 10.1126/scitranslmed.3005411 and PMC identifier 3824959.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prevention and early detection remain essential to decreasing cancer mortality. Screening DNA in Pap smears has the potential to increase the rate of early detection of endometrial and ovarian cancers. In this issue of Science Translational Medicine, Kinde and colleagues use advanced sequencing technology to evaluate DNA to screen for gynecologic malignancies.
Medical subject headings
- DNA, Neoplasm
- Endometrial Neoplasms
- Ovarian Neoplasms
- Papanicolaou Test
- Vaginal Smears